The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Retinal Disorders Therapy-Global Market Insights and Sales Trends 2025
Synopsis
Retinal disorders therapy includes medical interventions and treatments used to manage various retinal disorders, such as age-related macular degeneration, diabetic retinopathy, and retinal detachment.
The global Retinal Disorders Therapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Retinal Disorders Therapy in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Retinal Disorders Therapy market. Age Related Macular Degeneration, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diabetic Retinopathy segment is estimated at % CAGR for the next seven-year period.
The market for retinal disorders therapy is driven by the increasing prevalence of retinal disorders, particularly in the aging population, and the demand for effective and innovative treatments to preserve vision and prevent vision loss. The market's growth is also influenced by advancements in retinal imaging and drug delivery technologies.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Retinal Disorders Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Retinal Disorders Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Retinal Disorders Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Retinal Disorders Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Retinal Disorders Therapy covered in this report include ALLERGAN, AbbVie, Alimera Sciences, Janssen Biotech, Swedish Orphan Biovitrum, Roche, Bristol-Myers Squibb, Genzyme and Genentech, etc.
The global Retinal Disorders Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
ALLERGAN
AbbVie
Alimera Sciences
Janssen Biotech
Swedish Orphan Biovitrum
Roche
Bristol-Myers Squibb
Genzyme
Genentech
OCULAR THERAPEUTIX
Bausch & Lomb
UCBCares
Aier Eye Hospital
Alcon Holdings, Inc.
Eyebright Medical
Kanghong Pharmaceutical
Huaxia Eye Hospital
Xingqi Pharmaceutical
Global Retinal Disorders Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Retinal Disorders Therapy market, Segment by Type:
Age Related Macular Degeneration
Diabetic Retinopathy
Ocular Inflammatory Disease (Uveitis)
Macular Hole
Global Retinal Disorders Therapy market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Retinal Disorders Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Retinal disorders therapy includes medical interventions and treatments used to manage various retinal disorders, such as age-related macular degeneration, diabetic retinopathy, and retinal detachment.
The global Retinal Disorders Therapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Retinal Disorders Therapy in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Retinal Disorders Therapy market. Age Related Macular Degeneration, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diabetic Retinopathy segment is estimated at % CAGR for the next seven-year period.
The market for retinal disorders therapy is driven by the increasing prevalence of retinal disorders, particularly in the aging population, and the demand for effective and innovative treatments to preserve vision and prevent vision loss. The market's growth is also influenced by advancements in retinal imaging and drug delivery technologies.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Retinal Disorders Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Retinal Disorders Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Retinal Disorders Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Retinal Disorders Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Retinal Disorders Therapy covered in this report include ALLERGAN, AbbVie, Alimera Sciences, Janssen Biotech, Swedish Orphan Biovitrum, Roche, Bristol-Myers Squibb, Genzyme and Genentech, etc.
The global Retinal Disorders Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
ALLERGAN
AbbVie
Alimera Sciences
Janssen Biotech
Swedish Orphan Biovitrum
Roche
Bristol-Myers Squibb
Genzyme
Genentech
OCULAR THERAPEUTIX
Bausch & Lomb
UCBCares
Aier Eye Hospital
Alcon Holdings, Inc.
Eyebright Medical
Kanghong Pharmaceutical
Huaxia Eye Hospital
Xingqi Pharmaceutical
Global Retinal Disorders Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Retinal Disorders Therapy market, Segment by Type:
Age Related Macular Degeneration
Diabetic Retinopathy
Ocular Inflammatory Disease (Uveitis)
Macular Hole
Global Retinal Disorders Therapy market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Retinal Disorders Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Retinal Disorders Therapy
1.1 Retinal Disorders Therapy Market Overview
1.1.1 Retinal Disorders Therapy Product Scope
1.1.2 Retinal Disorders Therapy Market Status and Outlook
1.2 Global Retinal Disorders Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Retinal Disorders Therapy Market Size by Region (2018-2029)
1.4 Global Retinal Disorders Therapy Historic Market Size by Region (2018-2023)
1.5 Global Retinal Disorders Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Retinal Disorders Therapy Market Size (2018-2029)
1.6.1 North America Retinal Disorders Therapy Market Size (2018-2029)
1.6.2 Europe Retinal Disorders Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Retinal Disorders Therapy Market Size (2018-2029)
1.6.4 Latin America Retinal Disorders Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Retinal Disorders Therapy Market Size (2018-2029)
2 Retinal Disorders Therapy Market by Type
2.1 Introduction
2.1.1 Age Related Macular Degeneration
2.1.2 Diabetic Retinopathy
2.1.3 Ocular Inflammatory Disease (Uveitis)
2.1.4 Macular Hole
2.2 Global Retinal Disorders Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Retinal Disorders Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Retinal Disorders Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Retinal Disorders Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Retinal Disorders Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Retinal Disorders Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Retinal Disorders Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Retinal Disorders Therapy Revenue Breakdown by Type (2018-2029)
3 Retinal Disorders Therapy Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Retinal Disorders Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Retinal Disorders Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Retinal Disorders Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Retinal Disorders Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Retinal Disorders Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Retinal Disorders Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Retinal Disorders Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Retinal Disorders Therapy Revenue Breakdown by Application (2018-2029)
4 Retinal Disorders Therapy Competition Analysis by Players
4.1 Global Retinal Disorders Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Retinal Disorders Therapy as of 2022)
4.3 Date of Key Players Enter into Retinal Disorders Therapy Market
4.4 Global Top Players Retinal Disorders Therapy Headquarters and Area Served
4.5 Key Players Retinal Disorders Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Retinal Disorders Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 ALLERGAN
5.1.1 ALLERGAN Profile
5.1.2 ALLERGAN Main Business
5.1.3 ALLERGAN Retinal Disorders Therapy Products, Services and Solutions
5.1.4 ALLERGAN Retinal Disorders Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 ALLERGAN Recent Developments
5.2 AbbVie
5.2.1 AbbVie Profile
5.2.2 AbbVie Main Business
5.2.3 AbbVie Retinal Disorders Therapy Products, Services and Solutions
5.2.4 AbbVie Retinal Disorders Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 AbbVie Recent Developments
5.3 Alimera Sciences
5.3.1 Alimera Sciences Profile
5.3.2 Alimera Sciences Main Business
5.3.3 Alimera Sciences Retinal Disorders Therapy Products, Services and Solutions
5.3.4 Alimera Sciences Retinal Disorders Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Janssen Biotech Recent Developments
5.4 Janssen Biotech
5.4.1 Janssen Biotech Profile
5.4.2 Janssen Biotech Main Business
5.4.3 Janssen Biotech Retinal Disorders Therapy Products, Services and Solutions
5.4.4 Janssen Biotech Retinal Disorders Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Janssen Biotech Recent Developments
5.5 Swedish Orphan Biovitrum
5.5.1 Swedish Orphan Biovitrum Profile
5.5.2 Swedish Orphan Biovitrum Main Business
5.5.3 Swedish Orphan Biovitrum Retinal Disorders Therapy Products, Services and Solutions
5.5.4 Swedish Orphan Biovitrum Retinal Disorders Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Swedish Orphan Biovitrum Recent Developments
5.6 Roche
5.6.1 Roche Profile
5.6.2 Roche Main Business
5.6.3 Roche Retinal Disorders Therapy Products, Services and Solutions
5.6.4 Roche Retinal Disorders Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Roche Recent Developments
5.7 Bristol-Myers Squibb
5.7.1 Bristol-Myers Squibb Profile
5.7.2 Bristol-Myers Squibb Main Business
5.7.3 Bristol-Myers Squibb Retinal Disorders Therapy Products, Services and Solutions
5.7.4 Bristol-Myers Squibb Retinal Disorders Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Bristol-Myers Squibb Recent Developments
5.8 Genzyme
5.8.1 Genzyme Profile
5.8.2 Genzyme Main Business
5.8.3 Genzyme Retinal Disorders Therapy Products, Services and Solutions
5.8.4 Genzyme Retinal Disorders Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Genzyme Recent Developments
5.9 Genentech
5.9.1 Genentech Profile
5.9.2 Genentech Main Business
5.9.3 Genentech Retinal Disorders Therapy Products, Services and Solutions
5.9.4 Genentech Retinal Disorders Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 Genentech Recent Developments
5.10 OCULAR THERAPEUTIX
5.10.1 OCULAR THERAPEUTIX Profile
5.10.2 OCULAR THERAPEUTIX Main Business
5.10.3 OCULAR THERAPEUTIX Retinal Disorders Therapy Products, Services and Solutions
5.10.4 OCULAR THERAPEUTIX Retinal Disorders Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 OCULAR THERAPEUTIX Recent Developments
5.11 Bausch & Lomb
5.11.1 Bausch & Lomb Profile
5.11.2 Bausch & Lomb Main Business
5.11.3 Bausch & Lomb Retinal Disorders Therapy Products, Services and Solutions
5.11.4 Bausch & Lomb Retinal Disorders Therapy Revenue (US$ Million) & (2018-2023)
5.11.5 Bausch & Lomb Recent Developments
5.12 UCBCares
5.12.1 UCBCares Profile
5.12.2 UCBCares Main Business
5.12.3 UCBCares Retinal Disorders Therapy Products, Services and Solutions
5.12.4 UCBCares Retinal Disorders Therapy Revenue (US$ Million) & (2018-2023)
5.12.5 UCBCares Recent Developments
5.13 Aier Eye Hospital
5.13.1 Aier Eye Hospital Profile
5.13.2 Aier Eye Hospital Main Business
5.13.3 Aier Eye Hospital Retinal Disorders Therapy Products, Services and Solutions
5.13.4 Aier Eye Hospital Retinal Disorders Therapy Revenue (US$ Million) & (2018-2023)
5.13.5 Aier Eye Hospital Recent Developments
5.14 Alcon Holdings, Inc.
5.14.1 Alcon Holdings, Inc. Profile
5.14.2 Alcon Holdings, Inc. Main Business
5.14.3 Alcon Holdings, Inc. Retinal Disorders Therapy Products, Services and Solutions
5.14.4 Alcon Holdings, Inc. Retinal Disorders Therapy Revenue (US$ Million) & (2018-2023)
5.14.5 Alcon Holdings, Inc. Recent Developments
5.15 Eyebright Medical
5.15.1 Eyebright Medical Profile
5.15.2 Eyebright Medical Main Business
5.15.3 Eyebright Medical Retinal Disorders Therapy Products, Services and Solutions
5.15.4 Eyebright Medical Retinal Disorders Therapy Revenue (US$ Million) & (2018-2023)
5.15.5 Eyebright Medical Recent Developments
5.16 Kanghong Pharmaceutical
5.16.1 Kanghong Pharmaceutical Profile
5.16.2 Kanghong Pharmaceutical Main Business
5.16.3 Kanghong Pharmaceutical Retinal Disorders Therapy Products, Services and Solutions
5.16.4 Kanghong Pharmaceutical Retinal Disorders Therapy Revenue (US$ Million) & (2018-2023)
5.16.5 Kanghong Pharmaceutical Recent Developments
5.17 Huaxia Eye Hospital
5.17.1 Huaxia Eye Hospital Profile
5.17.2 Huaxia Eye Hospital Main Business
5.17.3 Huaxia Eye Hospital Retinal Disorders Therapy Products, Services and Solutions
5.17.4 Huaxia Eye Hospital Retinal Disorders Therapy Revenue (US$ Million) & (2018-2023)
5.17.5 Huaxia Eye Hospital Recent Developments
5.18 Xingqi Pharmaceutical
5.18.1 Xingqi Pharmaceutical Profile
5.18.2 Xingqi Pharmaceutical Main Business
5.18.3 Xingqi Pharmaceutical Retinal Disorders Therapy Products, Services and Solutions
5.18.4 Xingqi Pharmaceutical Retinal Disorders Therapy Revenue (US$ Million) & (2018-2023)
5.18.5 Xingqi Pharmaceutical Recent Developments
6 North America
6.1 North America Retinal Disorders Therapy Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Retinal Disorders Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Retinal Disorders Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Retinal Disorders Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Retinal Disorders Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Retinal Disorders Therapy Market Dynamics
11.1 Retinal Disorders Therapy Industry Trends
11.2 Retinal Disorders Therapy Market Drivers
11.3 Retinal Disorders Therapy Market Challenges
11.4 Retinal Disorders Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
